These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 21163580)

  • 21. Increase of carboxylesterase activity in Fasciola hepatica recovered from triclabendazole treated sheep.
    Scarcella S; Miranda-Miranda E; Cossío-Bayúgar R; Ceballos L; Fernandez V; Solana H
    Mol Biochem Parasitol; 2012 Oct; 185(2):151-3. PubMed ID: 22814337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrastructural changes to the tegumental system and the gastrodermal cells in adult Fasciola hepatica following in vivo treatment with the experimental fasciolicide, compound alpha.
    McConville M; Brennan GP; Flanagan A; Edgar HW; Castillo R; Hernández-Campos A; Fairweather I
    Parasitology; 2009 May; 136(6):665-80. PubMed ID: 19368745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fasciola hepatica: Histology of the Reproductive Organs and Differential Effects of Triclabendazole on Drug-Sensitive and Drug-Resistant Fluke Isolates and on Flukes from Selected Field Cases.
    Hanna R
    Pathogens; 2015 Jun; 4(3):431-56. PubMed ID: 26131614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fasciola hepatica: histological demonstration of apoptosis in the reproductive organs of flukes of triclabendazole-sensitive and triclabendazole-resistant isolates, and in field-derived flukes from triclabendazole-treated hosts, using in situ hybridisation to visualise endonuclease-generated DNA strand breaks.
    Hanna RE; Forster FI; Brennan GP; Fairweather I
    Vet Parasitol; 2013 Jan; 191(3-4):240-51. PubMed ID: 23062689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental infection of bighorn sheep with liver flukes (Fasciola hepatica).
    Foreyt WJ
    J Wildl Dis; 2009 Oct; 45(4):1217-20. PubMed ID: 19901401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentiation of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica following its co-administration with the metabolic inhibitor, ketoconazole.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Vet Parasitol; 2012 Feb; 184(1):37-47. PubMed ID: 21872399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fasciola hepatica: comparative effects of host resistance and parasite intra-specific interactions on size and reproductive histology in flukes from rats infected with isolates differing in triclabendazole sensitivity.
    Hanna RE; Gordon AW; Moffett D; Edgar HW; Oliver LF; McConnell S; Shaw L; Brennan GP; Fairweather I
    Vet Parasitol; 2011 Jun; 178(3-4):251-63. PubMed ID: 21333449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A study of a restricted programme of strategic dosing against Fasciola hepatica with triclabendazole.
    Fawcett AR
    Vet Rec; 1990 Nov; 127(20):492-3. PubMed ID: 2275087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs.
    Alvarez L; Moreno G; Moreno L; Ceballos L; Shaw L; Fairweather I; Lanusse C
    Vet Parasitol; 2009 Oct; 164(2-4):211-6. PubMed ID: 19560276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fasciola hepatica: Histological changes in the somatic and reproductive tissues of liver fluke following closantel treatment of experimentally-infected sheep.
    Scarcella S; Hanna RE; Brennan GP; Solana H; Fairweather I
    Vet Parasitol; 2016 Jan; 215():38-47. PubMed ID: 26790736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of two assays, a faecal egg count reduction test (FECRT) and a coproantigen reduction test (CRT), for the diagnosis of resistance to triclabendazole in Fasciola hepatica in sheep.
    Flanagan A; Edgar HW; Gordon A; Hanna RE; Brennan GP; Fairweather I
    Vet Parasitol; 2011 Mar; 176(2-3):170-6. PubMed ID: 21112153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica by co-treatment with ketoconazole.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Vet Parasitol; 2011 May; 177(3-4):305-15. PubMed ID: 21208747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increase of gluthatione S-transferase, carboxyl esterase and carbonyl reductase in Fasciola hepatica recovered from triclabendazole treated sheep.
    Scarcella S; Solana MV; Fernandez V; Lamenza P; Ceballos L; Solana H
    Mol Biochem Parasitol; 2013 Oct; 191(2):63-5. PubMed ID: 24041589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extension of the prepatent period of Fasciola hepatica in infected animals following treatment with triclabendazole.
    Büscher G; Bowen FL; Strong MB; Allison JR; Richards RJ
    Vet Rec; 1987 May; 120(19):460-1. PubMed ID: 3603988
    [No Abstract]   [Full Text] [Related]  

  • 35. Immature Fasciola gigantica: Time-dependent ultrastructural changes following in vivo treatment with triclabendazole.
    P A AS; S M A A
    Acta Trop; 2019 Aug; 196():15-21. PubMed ID: 31028722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance of Fasciola hepatica to triclabendazole.
    Overend DJ; Bowen FL
    Aust Vet J; 1995 Jul; 72(7):275-6. PubMed ID: 8534235
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification of a field isolate of Fasciola hepatica resistant to albendazole and susceptible to triclabendazole.
    Sanabria R; Ceballos L; Moreno L; Romero J; Lanusse C; Alvarez L
    Vet Parasitol; 2013 Mar; 193(1-3):105-10. PubMed ID: 23273779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The comparative efficacy of four anthelmintics against a natural acquired Fasciola hepatica infection in hill sheep flock in the west of Ireland.
    Mooney L; Good B; Hanrahan JP; Mulcahy G; de Waal T
    Vet Parasitol; 2009 Oct; 164(2-4):201-5. PubMed ID: 19556063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of vitellogenesis and spermatogenesis by triclabendazole (TCBZ) in a TCBZ-resistant isolate of Fasciola hepatica following incubation in vitro with a P-glycoprotein inhibitor.
    Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Parasitology; 2014 Jul; 141(8):1064-79. PubMed ID: 24889697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clonal amplification of Fasciola hepatica in Galba truncatula: within and between isolate variation of triclabendazole-susceptible and -resistant clones.
    Hodgkinson JE; Cwiklinski K; Beesley N; Hartley C; Allen K; Williams DJL
    Parasit Vectors; 2018 Jun; 11(1):363. PubMed ID: 29941045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.